ReviewFrontiers in neurology2025
Artificial intelligence in the task of segmentation and classification of brain metastases images: current challenges and future opportunities.
Review in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Artificial Intelligence-Based MRI Segmentation in Glioblastoma and Single Brain Metastasis: An Exploratory Study of Diagnostic and Prognostic Value.Life (Basel, Switzerland) · 2026Article
- Primary glioblastoma mimicking brain metastasis in ALK-positive lung adenocarcinoma: a case report and literature review.Frontiers in oncology · 2026Article
- DPEA-Net: a clinically-oriented lightweight 3D CNN for glioma segmentation in multiparametric MRI.Frontiers in neurologyArticle
- GMANet: a CPU-only ultra-lightweight 3D CNN for real-time glioma triage in resource-limited environments.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain metastases (BM) are common complications of advanced cancer, posing significant diagnostic and therapeutic challenges for clinicians. Therefore, the ability to accurately detect, segment, and classify brain metastases is crucial. This review focuses on the application of artificial intelligence (AI) in brain metastasis imaging analysis, including classical machine learning and deep learning techniques. It also discusses the role of AI in brain metastasis detection and segmentation, the differential diagnosis of brain metastases from primary brain tumors such as glioblastoma, the identification of the source of brain metastases, and the differentiation between radiation necrosis and recurrent tumors after radiotherapy. Additionally, the advantages and limitations of various AI methods are discussed, with a focus on recent advancements and future research directions. AI-driven imaging analysis holds promise for improving the accuracy and efficiency of brain metastasis diagnosis, thereby enhancing treatment plans and patient prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.